Cochlear Ltd higher Wednesday, outperforms the Health Care sector
Here is the latest company close update for Cochlear Ltd, COH.
Cochlear
Cochlear talks up huge pipeline as shares slump on outlook miss
Digital savvy seniors and an expanding body of research on the benefits of hearing to cognition underpin Cochlear’s huge long term growth trajectory, chief executive Dig Howitt says.
ASX trims gains as Cochlear, Origin falls weigh; jobs data dims rates hopes
AUD rises on ‘quite tight’ jobs market. Cochlear, Origin sink on profit miss . Telstra rises despite profit fall. Treasury Wine lifts on China boost. Goodman dips on mixed results. Nufarm tumbles on earnings downgrade.
ASX 200 lifts as MinRes gains; Bellevue tanks
Investors welcome MinRes cash gains, price wins. Bellevue Gold downgraded on discounted equity raise. Inflation uptick may force RBA hike. Key exit triggers Cochlear executive rehaul.
Mission-oriented ‘moonshots’ the way to go
Universities are uniquely positioned to lead very specific and ambitious ‘moonshot’ research programs aimed at solving major global problems.
Business in tizz over meeting with Beijing minister
Executives from Rio Tinto and Cochlear are expected to join the private event with China’s visiting foreign minister, as even business figures criticise Paul Keating’s “stupid” meeting with Wang Yi.
ASX 200 ends at record high
ASX 200 sets all-time high at close. Life360 soars 38 per cent on earnings beat. ASIC wants crime-linked Prospero wound up. China manufacturing activity better than expected but still weak.
Cochlear to pay record dividend but is best yet to come?
Cochlear has delivered a bumper first half profit, but at least one analyst says the company could be doing even better than the numbers suggest.
ASX ends flat; Lendlease leads property falls
Economy to remain resilient: Westpac. Bendigo Bank sees competition issues in ANZ’s Suncorp bid. Boral gains, Seven Group dips on takeover play. APM, A2 Milk soar.
ASX ends little changed; Boral jumps
RBA boss says lower inflation data key to unlocking rate cuts. Callide Power Trading faces court action. PwC’s Labor donation questioned. Stokes-backed Boral ups guidance.
ASX drops; Costa, Cochlear rally in bleak session
ASX led lower by tech and discretionary stocks. Nanosonics falls on profit slump, Cochlear and Costa leap of earnings, Coles profit dips and Tyro sell off continues.
Biotechs applaud tax cut move to keep Aussie research
The federal government’s ‘patent box’ will almost halve the tax rate on Australian research that is commercialised locally.
ASX200 ends down 0.1% as banks, miners slip
The S&P/ASX 200 finished slightly weaker after a late retreat, with the big banks and miners in the red after mixed leads from Wall Street.
Vaccination not the only sharemarket challenge
Bond yields rising, stimulus programs running out – the risks are out there for sharemarket investors.
ASX ends lower as Evergrande falls
Australia’s sharemarket fell slightly at the end of a volatile week. The S&P/ASX 200 index closed down 0.4% at 7342.6 and suffered its first three-week fall in seven months.
ASX recovers to end flat, RBA holds rates
The ASX recovered to finish steady after the RBA said the economy will ‘bounce back’ from Delta. Iron ore prices tumbled.
How Cochlear helped ‘Hulk’ hear again
Face masks are annoying but they delivered Cochlear an unexpected uplift during the global pandemic.
ASX falls 5 days in a row, Cochlear drops
ASX 200 closes slightly lower. Iron ore futures rising. Cochlear guidance disappoints, Sydney Airport losses deepen, Stockland shares down.
We’re all ears: tech plan wins over business
Bionic ear maker Cochlear has backed Josh Frydenberg’s ‘patent box’’ tax break for innovation predicting it could create more highly paid jobs in Australia.
Improving safety of bionic devices
Physicists at the University of Sydney have developed a new method of testing if bionic devices are leak-proof.
Original URL: https://www.theaustralian.com.au/topics/cochlear